Results 231 to 240 of about 476,894 (337)
Clustering therapeutic drugs using FDA Adverse Event Reporting System
Shinkawa Ryutaro+4 more
openalex +4 more sources
Patient safety incident reporting in Indonesia: an analysis using World Health Organization characteristics for successful reporting [PDF]
Barraclough, Simon+3 more
core +1 more source
Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system. [PDF]
Chen W, Xie Y, Li Q, Zhu Z, Li X, Zhu H.
europepmc +1 more source
BX‐001N, a polyethylene glycol‐conjugated bilirubin 3α nanoparticle, is the first GMP‐grade, synthetic bilirubin‐based nanomedicine. It effectively attenuates acute renal injury, facilitates subacute renal recovery, and suppresses chronic fibrosis after renal ischemia/reperfusion injury via anti‐oxidant and immune‐modulating activity.
Ji‐Jing Yan+13 more
wiley +1 more source
Participation in a System-Thinking Simulation Experience Changes Adverse Event Reporting
Jill S. Sanko, Mary Mckay
openalex +1 more source
Drug-Related Hypertension: A Disproportionality Analysis Leveraging the FDA Adverse Event Reporting System. [PDF]
Zhu H, Pan L, Lui H, Zhang J.
europepmc +1 more source
DexaPatch, an implantable, low‐swelling amphiphilic hydrogel system containing dexamethasone‐PLGA microparticles, is developed and characterized for sustained local steroid release to reduce postoperative inflammation in tight surgical spaces. DexaPatch significantly reduces postoperative edema and fibrosis in a rabbit model of anterior spinal surgery,
Stephen W. Linderman+6 more
wiley +1 more source
An investigation of drug-induced mental disorders in the children and adolescents population utilizing the FDA adverse event reporting system. [PDF]
Tang L+6 more
europepmc +1 more source
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto+2 more
wiley +1 more source
This study developed 3D‐printable THA‐Col microgels for delivering BMP‐7 cmRNA. The key result is that hMSCs transfected on the biomaterials showed BMP‐7 secretion levels comparable to pre‐transfected hMSCs, therefore introducing a cmRNA‐activated matrix to promote bone healing.
Daphne van der Heide+7 more
wiley +1 more source